Apollo Health and Lifestyle (AHLL) has planned to raise funds for its expansion over the next 5 years. It is ready to invest up to Rs. 500 crore and has plans to invite private equity investors to participate in this growth opportunity.
AHLL is a subsidiary of Apollo Hospitals Enterprise Ltd and it operates a network of primary care and specialty care formats clinics across India. In the primary care space, it has 5 formats -- Apollo Clinics, Apollo Sugar, Apollo Diagnostics, Apollo White and Apollo Dialysis. It also has Apollo Cradle and Apollo Spectra Hospitals as part of its portfolio.
Advertisement"AHLL operates in a large and rapidly growth healthcare market with a portfolio of formats that have strong synergies amongst themselves and enable Apollo to provide a continuum of care to patients. AHLL has undergone a significant expansion in the past 3 years and has plans for continued growth and expansion over the next 5 years," said the company.
Apollo is in the midst of a Rs1,600 crore ($251 million) expansion program to add 1,590 beds and eight health-care facilities over the next two years. It also plans to raise Rs750 crore through allotment of equity shares on a rights basis for expansion and possible acquisitions.
"The idea is to bring all the different retail formats like the general and specialty clinics, premium birthing centers Cradle, daycare surgery centers and home healthcare under one entity. Different segments will share customer engagement and marketing services while each one will have separate team for service delivery. We are looking at renewed growth from the retail venture in the next three to five years," said Sangita Reddy, joint managing director, Apollo Hospitals.
AHLL's plan is to double the number of clinics in next three years and also increase its presence in the Gulf region and Africa.
"AHLL has aggressive plans for the sugar clinics, the number of which will scale up from 25 to 200 in five years. We are also looking for international partners in diabetes care. We want to grow from Rs 200 crore to Rs 2,000 crore in three years, both organically and inorganically," said Neeraj Garg, CEO of AHLL.
P2 Million in 2030? Number of Deaths Due to Cigarette Smoking to Double Up in China Blood Test May Predict Heart Attack Risk in Individuals With Chest Pain M
You May Also Like